Molecular Formula | C7H10O3 |
Molar Mass | 142.15 |
Density | 1.198±0.06 g/cm3(Predicted) |
Boling Point | 115 °C(Press: 0.01 Torr) |
Solubility | Chloroform (Sparingly), Methanol (Slightly) |
Vapor Presure | 0.011-0.02Pa at 20-25℃ |
Appearance | Oil |
Color | Yellow to Very Dark Brown |
pKa | 10.04±0.40(Predicted) |
Storage Condition | 2-8°C |
Use | This product is for scientific research only and shall not be used for other purposes. |
LogP | 0.6 at 20℃ and pH6.4 |
surface tension | 59.89mN/m at 1g/L and 20 ℃ |
Application | 4-propyl-5-hydroxyfuran-2-one can be used as a pharmaceutical synthesis intermediate, if the following reaction occurs: a suitable amount of 18G (S)-2-aminobutyramide hydrochloride was mixed with 3.3 ml of ammonia in Isopropanol (3.7-moL/L). Free, then reacted with 19g of 4-propyl-5-hydroxyfuran-2-one at room temperature; 18.44G of solid product was obtained. The yield was 61.0%. Alternatively, an isopropanol solution containing 5-hydroxy-4-n-propyl-furan-2-one is slowly added dropwise to a solution of free (S)-2-aminobutanamide in isopropanol, the reaction was stirred magnetically overnight at room temperature, and the next step was carried out without treatment. ESI-MS(m/z):227[M H]. |
Use | 4-propyl-5-hydroxyfuran-2-one can be used as a pharmaceutical synthesis intermediate, as in the preparation of the buvaracetam (Brivaracetam) intermediate. The chemical name of buvaracetam is (2S)-2-[(4R)-2-oxo-4-n-propylpyrrolidinyl] butanamide, which is a new type of antiepileptic drug developed by UCB in Belgium. |